Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.
Recent: |
|
Past: |
|
Sisi Wei and Ryann Grochowski Jones on the past and future of their work at ProPublica → Read More
The past two years have been a time of reckoning for pharmaceutical manufacturers over their role in promoting opioid drugs that have fed a national → Read More
ProPublica found that drugmakers spent less to market opioids to doctors in 2016 than in prior years. Studies have shown that payments to doctors are linked to more prescriptions for the drugs. → Read More
The military spends more than a billion dollars a year to clean up sites its operations have contaminated with toxic waste and explosives. These sites exist in every state in the country. Some are located near schools, residential neighborhoods, rivers and lakes. A full map of these sites has never been made public – until now. → Read More
The military spends more than a billion dollars a year to clean up sites its operations have contaminated with toxic waste and explosives. A map of these sites has never been made public — until now. Find ones near you. → Read More
Announcing four researchers who will advise us on our data-journalism projects. → Read More
Physicians and health policy experts cite demographics and healthier lifestyles as possible reasons. → Read More
Medicare patients in Hawaii take fewer opioid painkillers and fewer antibiotics, on average, than those in any other state, ProPublica reports. → Read More
People who live in the Aloha State are less likely to use opioid painkillers or be prescribed antibiotics than are mainland dwellers. Healthy lifestyles have a lot to do with that. → Read More
People who live in the Aloha State are less likely to use opioid painkillers or be prescribed antibiotics than are mainland dwellers. Healthy lifestyles have a lot to do with that. → Read More
ProPublica has been publishing data on conflicts of interest in medicine since 2010. We’ve updated our Dollars for Docs database with billions of dollars in payments made last year. → Read More
In 2011, just 41 health care providers prescribed more than $5 million each in medicines under Medicare Part D. In 2015, that number was 514. The rise of expensive hepatitis C drugs is a factor. → Read More
Our goal was to compare U.S. hospitals based on the percentage of their affiliated physicians who receive payments of various sizes from pharmaceutical and medical device companies. → Read More
An analysis of Medicare data shows that the more money a doctor gets from pharmaceutical companies, the more likely he or she is to prescribe brand-name medications. And that influences cost. → Read More
ProPublica and Mashable are proud to announce our first-ever Diversity Mentorship Program at the Online News Association conference in Los Angeles this year. → Read More
The latest data on payments from drug and device companies to doctors show that many doctors received payments on 100 or more days last year. Some received payments on more days than they didn't. → Read More
Congress wouldn’t allow Medicare to pay for benzodiazepines such as Xanax and Ativan until 2013. Now, the medications are among the most prescribed in its drug program. → Read More
The ridesharing service published a report last week with Mothers Against Drunk Driving connecting the rise of Uber to a drop in drunk driving accidents. Except the connection isn't so clear. → Read More
Flaws in information submitted to Open Payments, a government database of financial relationships in the medical field, complicated our analysis. → Read More
Our comprehensive analysis of drug company spending on doctors in the last five months of 2013 shows the most-promoted products typically were not cures, breakthroughs or top sellers. → Read More